CV is a tag-along, with a stated time frame of 0-12 months (as do all the other endpoints), not two years. And I already stated that it's an "other outcome" not a primary or secondary.
Calling a study's "other outcome" as the goal, is dumb. And holding up the data for a reach goal, beyond the stated timeline, is incredibly stupid and grasping at straws. The primary (and possibly secondary) endpoints are what matter. Especially when we consider the breadth and depth of data that already supports the "other outcomes" related to CV (R-it, Respect, etc.).
As for the data release, I misinterpreted your statement, taking it that management was planning to withhold that data until Mid 2023, not the researchers (who themselves should be tried for medical malpractice for withholding all data for so long past the completion date). I interpreted it that way because most of the study's data release dates ultimately seem to be up to the company.
Market Data 
Markets 
AI
